NCT01865669View on ClinicalTrials.gov

In-vitro Myometrial Contractility After Oxytocin Pre-exposure in Women With Advanced Maternal Age and Morbid Obesity

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 13, 2017

Study Completion Date

June 13, 2017

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Oxytocin

Oxytocin, 10-10mol/L to 10-5mol/L

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT01865669 - In-vitro Myometrial Contractility After Oxytocin Pre-exposure in Women With Advanced Maternal Age and Morbid Obesity | Biotech Hunter | Biotech Hunter